National Comprehensive Cancer Network



Educational Events & Programs

OVERVIEW

On June 15, 2017, the National Comprehensive Cancer Network® (NCCN®) will host a summit focused on current oncology patient safety issues and access considerations under the new administration. The summit will provide an opportunity for a varied group of stakeholders including providers, payers, patients, patient advocacy organizations, and industry, to thoughtfully discuss patient access to high quality, effective, and efficient oncology care, as well as to disseminate advances in oncology patient safety systems best practices, processes, and policies. The summit will also explore shifting healthcare priorities under the Trump administration and any implications for safety and access to high quality cancer care.

A subsequent article of the summit will be published in the Journal of the National Comprehensive Cancer Network―JNCCN.

Please check back often for additional updates regarding the summit. If you have any questions, please contact Katy Winckworth-Prejsnar.

MODERATOR

Clifford Goodman, PhD
Senior Vice President
The Lewin Group

 

 

 

 

AGENDA*

8:30 – 9:30 AM
Breakfast

9:30 – 9:40 AM
Welcome and Introductions
Robert W. Carlson, MD
National Comprehensive Cancer Network

9:40 – 10:10 AM
Safety and Accountability in Oncology Care
Robert M. Califf, MD, MACC (Invited)
Former FDA Commissioner

10:10 – 10:20 AM
Break

10:25 – 11:45 AM
Panel Discussion:
Safety and Accountability in Cancer Care; Past, Present and Future

Moderated by Clifford Goodman, PhD, The Lewin Group

Panelists
Robert M. Califf, MD, MACC (Invited)
Former FDA Commissioner

Amy P. Abernethy, MD, PhD
Flatiron

F. Marc Stewart, MD
Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance

Randy Burkholder
PhRMA 

Terry Langbaum, MHS
The Johns Hopkins Hospital

11:45 AM – 12:45 PM
Lunch

12:50 – 1:20 PM
Patient Access to Safe, High Quality Cancer Care Under a New Administration

1:20 – 2:40 PM
Panel Discussion:
Barriers and Opportunities in Ensuring Access to Safe, High Quality Cancer Care

Moderated by Clifford Goodman, PhD, The Lewin Group

Panelists:

Lee Newcomer, MD, MHA
UnitedHealthcare  

Caroline Pearson
Avalere

Rodney L. Whitlock, PhD
ML Strategies

Bruce Gould, MD
Northwest Georgia Oncology Centers

2:45 PM
Wrap-up and Conclusions
Robert W. Carlson, MD
National Comprehensive Cancer Network

*Subject to change.


SUPPORTERS

Supported by Adaptive Biotechnologies; AmerisourceBergen; Apobiologix, a division of ApoPharma USA, Inc.; EMD Serono; Gilead Sciences, Inc.; HELSINN; Incyte Corporation; Janssen Oncology; National Decision Support Company; and Pharmacyclics LLC, An AbbVie Company. Sponsored by AstraZeneca; Boehringer Ingelheim Pharmaceuticals, Inc.; Boston Biomedical, Inc.; and Dendreon. This activity is supported by a contribution from Lilly. Supported by an independent educational grant from Merck & Co., Inc. Supported by an unrestricted sponsorship from TESARO.

(As of April 11, 2017)

PROGRAM LOCATION

The National Press Club
529 14th Street, NW
Washington, DC 20045

INTENDED AUDIENCE

This summit is intended for providers, payers, patients, patient advocacy organizations, industry, and other relevant stakeholders.

FEES

Before 5.19.17 After 5.19.17

Government

$40 $50

Health Care Professionals (Other)

$40 $50

Industry

$65 $75

NCCN Member Institution Employees*

$20 $25
Nonprofit/Academia $40 $50
Physician $40 $50

 

*As a benefit of membership, NCCN extends a 50% discount off the registration fee to staff employed at NCCN Member Institutions. For a list of NCCN Member Institutions, please visit: http://www.nccn.org/members/network.aspx. Please contact Liz Rieder to learn how to apply this discount.


Access the Library of White Papers!

NCCN offers a broad library of white papers from previous summits that may be pertinent to your organization.

View Supporter Opportunities.

NCCN offers organizations various supporter opportunities.